Twenty-four months follow-up of chronic central serous chorioretinopathy patients after treatment with oral eplerenone or half-dose photodynamic therapy, and crossover treatment: SPECTRA trial report No. 4

被引:0
|
作者
van Rijssen, Th. J. [1 ]
Feenstra, H. M. A. [1 ]
van Dijk, E. H. C. [1 ]
Tsonaka, R. [2 ]
Diederen, R. M. H. [3 ]
Hoyng, C. B. [4 ]
Schlingemann, R. O. [3 ]
Boon, C. J. F. [1 ,3 ]
机构
[1] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands
[3] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:18 / 18
页数:1
相关论文
共 48 条
  • [41] Re: van Dijk et al: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The PLACE trial
    Calugaru, Dan
    Calugaru, Mihai
    OPHTHALMOLOGY, 2019, 126 (01) : E10 - E11
  • [42] Pigment epithelial detachments in chronic central serous chorioretinopathy: Effect of half-dose photodynamic therapy versus high-density subthreshold micropulse laser PLACE trial report No. 5
    van Dijk, E. H. C.
    Hahn, L.
    van Rijssen, T. J.
    Scholz, P.
    Breukin, M. B.
    Souied, E. H.
    MacLaren, R. E.
    Querques, G.
    Fauser, S.
    Downes, S. M.
    Hoyng, C. B.
    Boon, C. J. F.
    ACTA OPHTHALMOLOGICA, 2020, 98 : 40 - 41
  • [43] Comparison of subthreshold micropulse laser (577nm) treatment and half dose photodynamic therapy in patients with chronic central serous chorioretinopathy
    Scholz, Paula
    Erso, Lebriz
    Fauser, Sascha
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [44] Re: van Dijk et al: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The PLACE trial Reply
    van Dijk, Elon H. C.
    Fauser, Sascha
    Breukink, Myrte B.
    Blanco-Garavito, Rocio
    Keunen, Jan E. E.
    Groenewoud, Joannes M. M.
    Peters, Petrus J. H.
    Dijkman, Greet
    Souied, Eric H.
    MacLaren, Robert E.
    Querques, Giuseppe
    Downes, Susan M.
    Hoyng, Carel B.
    Boon, Camiel J. F.
    OPHTHALMOLOGY, 2019, 126 (01) : E11 - E11
  • [45] Comparison of visual and anatomical outcomes of half-dose photodynamic therapy and 689 nm laser treatment (pseudo-PDT) in eyes with chronic central serous chorioretinopathy.
    Russo, Andrea
    Cancarini, Anna
    Gambicorti, Elena
    Duse, Sarah
    Scaroni, Nicolo
    Costagliola, Ciro
    Semeraro, Francesco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [46] Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555)
    Parodi, Maurizio Battaglia
    Iacono, Pierluigi
    OPHTHALMOLOGY, 2019, 126 (04) : E29 - E30
  • [47] Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555) Reply
    van Dijk, Elon H. C.
    Fauser, Sascha
    Breukink, Myrte B.
    Blanco-Garavito, Rocio
    Groenewoud, Joannes M. M.
    Keunen, Jan E. E.
    Peters, Petrus J. H.
    Dijkman, Greet
    Souied, Eric H.
    MacLaren, Robert E.
    Querques, Giuseppe
    Downes, Susan M.
    Hoyng, Carel B.
    Boon, Camiel J. F.
    OPHTHALMOLOGY, 2019, 126 (04) : E30 - E31
  • [48] Three-Year Follow-Up Detecting Choroidal Neovascularization with Swept Source Optical Coherence Tomography Angiography (SS-OCTA) after Successful Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Esteban-Floria, Olivia
    Perez-Rivases, Guillermo
    Honrubia-Grijalbo, Ana
    Bartolome-Sese, Isabel
    Diaz-Barreda, Maria Dolores
    Boned-Murillo, Ana
    Cisneros-Arias, Pablo
    Mateo-Gabas, Javier
    Ascaso-Puyelo, Francisco-Javier
    DIAGNOSTICS, 2023, 13 (17)